Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Lee Weiner, M.D.

Co-Author

This page shows the publications co-authored by Howard Weiner and Laura Cox.
Connection Strength

5.092
  1. Gut Microbiome in Progressive Multiple Sclerosis. Ann Neurol. 2021 06; 89(6):1195-1211.
    View in: PubMed
    Score: 0.934
  2. The microbiome requires a genetically susceptible host to induce central nervous system autoimmunity. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):27764-27766.
    View in: PubMed
    Score: 0.902
  3. The sex-specific interaction of the microbiome in neurodegenerative diseases. Brain Res. 2019 12 01; 1724:146385.
    View in: PubMed
    Score: 0.829
  4. Microbiota Signaling Pathways that Influence Neurologic Disease. Neurotherapeutics. 2018 01; 15(1):135-145.
    View in: PubMed
    Score: 0.742
  5. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021 08 13; 12(1):4907.
    View in: PubMed
    Score: 0.238
  6. Regulation of splenic monocyte homeostasis and function by gut microbial products. iScience. 2021 Apr 23; 24(4):102356.
    View in: PubMed
    Score: 0.232
  7. Calorie restriction slows age-related microbiota changes in an Alzheimer's disease model in female mice. Sci Rep. 2019 11 29; 9(1):17904.
    View in: PubMed
    Score: 0.212
  8. Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila. Cell Host Microbe. 2019 12 11; 26(6):779-794.e8.
    View in: PubMed
    Score: 0.212
  9. Acute microglia ablation induces neurodegeneration in the somatosensory system. Nat Commun. 2018 11 01; 9(1):4578.
    View in: PubMed
    Score: 0.196
  10. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018 06; 83(6):1147-1161.
    View in: PubMed
    Score: 0.191
  11. Investigation of probiotics in multiple sclerosis. Mult Scler. 2018 01; 24(1):58-63.
    View in: PubMed
    Score: 0.185
  12. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016 06 28; 7:12015.
    View in: PubMed
    Score: 0.167
  13. Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors. Sci Rep. 2019 08 28; 9(1):12460.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.